Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Malaria Journal|May 26, 2023
Pharmacopeial quality of artemether-lumefantrine anti-malarial agents in UgandaMoses Ocan, Loyce Nakalembe, Caroline Otike, et al.Medrxiv : the Preprint Server for Health Sciences|June 30, 2025
A High-Performance Liquid Chromatography-Mass Spectrometry method for simultaneous determination of dolutegravir, nevirapine, efavirenz, rifampicin and rifapentine concentrations in human plasmaDenis Omali, Moses Ocan, Hindum Lanyero, et al.The Journal of Antimicrobial Chemotherapy|September 22, 2018
High efavirenz serum concentrations in TB/HIV-coinfected Ugandan adults with a CYP2B6 516 TT genotype on anti-TB treatmentAmrei von Braun, Barbara Castelnuovo, Bruno Ledergerber, et al.AIDS Research and Therapy|September 9, 2023
Dolutegravir use over 48 weeks is not associated with worsening insulin resistance and pancreatic beta cell function in a cohort of HIV-infected Ugandan adultsFrank Mulindwa, Barbara Castelnuovo, Nele Brusselaers, et al.Journal of the International AIDS Society|May 11, 2022
Oral pre-exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort studyYunia Mayanja, Onesmus Kamacooko, Jane Frances Lunkuse, et al.BMC Infectious Diseases|September 2, 2014
Therapeutic drug monitoring of nevirapine in saliva in Uganda using high performance liquid chromatography and a low cost thin-layer chromatography techniqueMohammed Lamorde, Quirine Fillekes, Kim Sigaloff, et al.Research Square|August 14, 2023
Blood glucose outcomes of anti-retroviral therapy naïve Ugandan people with HIV with pre-diabetes mellitus initiated on dolutegravir for 48 weeksFrank Mulindwa, Jean-Marc Schwarz, Nele Brusselaers, et al.New Microbes and New Infections|March 19, 2026
Amikacin exposure in MDR-TB patients in Uganda: Revisiting old drugs in a new era of resistance - A pharmacokinetic assessmentJan Hongler, Sabine Haller, Akello Susan Adakun, et al.Wellcome Open Research|July 5, 2024
Pharmacokinetics of drugs used to treat drug sensitive-tuberculosis in breastfeeding mother-infant pairs: An observational pharmacokinetic studyRitah Nakijoba, Aida Nakayiwa Kawuma, Francis Williams Ojara, et al.BMC Infectious Diseases|July 29, 2024
Blood glucose outcomes of anti-retroviral therapy naïve Ugandan people with HIV with pre-diabetes mellitus initiated on dolutegravir for 48 weeksFrank Mulindwa, Jean-Marc Schwarz, Nele Brusselaers, et al.Pageof 3